{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:01:41Z","timestamp":1792839701261,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.cgh.2016.06.023","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T18:40:54Z","timestamp":1467744054000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents"],"prefix":"10.1016","volume":"15","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.06.023_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)69374-4","article-title":"Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study","volume":"368","author":"Amin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.06.023_bib2","doi-asserted-by":"crossref","first-page":"e0139015","DOI":"10.1371\/journal.pone.0139015","article-title":"Replication inhibition of hepatitis B virus and hepatitis C virus in co-infected patients in Chinese population","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2016.06.023_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1053\/jhep.2002.36509","article-title":"HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course","volume":"36","author":"Sagnelli","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.06.023_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2","article-title":"Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance","volume":"58","author":"Fukuda","year":"1999","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cgh.2016.06.023_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2003.10.048","article-title":"Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection","volume":"126","author":"Pollicino","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.06.023_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13256-015-0630-8","article-title":"Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report","volume":"9","author":"Ende","year":"2015","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.cgh.2016.06.023_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/hepr.12578","article-title":"Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with HBV\/HCV co-infection","volume":"46","author":"Takayama","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2016.06.023_bib8","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/cid\/civ474","article-title":"Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir","volume":"61","author":"Collins","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.06.023_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcv.2016.02.026","article-title":"Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge","volume":"78","author":"De Monte","year":"2016","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cgh.2016.06.023_bib10","unstructured":"EMA reviews direct-acting antivirals for hepatitis C. 2016. Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Direct-acting_antivirals_indicated_for_treatment_of_hepatitis_C_(interferon-free)\/human_referral_prac_000057.jsp&mid=WC0b01ac05805c516f. Accessed April 20, 2016."},{"key":"10.1016\/j.cgh.2016.06.023_bib11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/0016-5085(94)90766-8","article-title":"Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis","volume":"106","author":"Liaw","year":"1994","journal-title":"Gastroenterology"},{"issue":"Suppl 13","key":"10.1016\/j.cgh.2016.06.023_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02990102","article-title":"Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection","volume":"37","author":"Liaw","year":"2002","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2016.06.023_bib13","first-page":"E1264","article-title":"Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line","volume":"111","author":"Yang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cgh.2016.06.023_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.03.003","article-title":"Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-gamma-induced protein 10 levels in HBV\/HCV-coinfected patients","volume":"21","author":"Wiegand","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2016.06.023_bib15","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"Meissner","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2016.06.023_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.06.023_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12072-008-9056-3","article-title":"Hepatitis B reactivation after chemotherapy: two decades of clinical research","volume":"2","author":"Lau","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2016.06.023_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.06.023_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.3253","article-title":"Regulation of hepatic innate immunity by hepatitis C virus","volume":"19","author":"Horner","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2016.06.023_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy","volume":"148","author":"Loomba","year":"2008","journal-title":"Ann Intern Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516303706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516303706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:21:08Z","timestamp":1761542468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516303706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1542356516303706"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.06.023","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}